Reaction
Metastases To The Mediastinum reporting signals
As of the last recalculation, Metastases To The Mediastinum appears in 410 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is GOSERELIN (PRR 87.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Goserelin | 22 | 87.8 | 88.0 |
| Anastrozole Tablets | 31 | 79.3 | 79.4 |
| Exemestane | 28 | 71.2 | 71.2 |
| Everolimus Tablets | 22 | 70.3 | 70.4 |
| Fulvestrant | 39 | 66.1 | 66.2 |
| Mesna Injection | 10 | 62.9 | 63.0 |
| Letrozole Tablets | 52 | 62.7 | 62.8 |
| Mesna | 10 | 61.8 | 61.9 |
| Ribociclib | 35 | 61.5 | 61.5 |
| Letrozole | 63 | 61.2 | 61.2 |
| Anastrozole | 36 | 54.5 | 54.5 |
| Lapatinib | 15 | 50.9 | 51.0 |
| Everolimus | 45 | 50.3 | 50.4 |
| Gefitinib | 8 | 45.9 | 45.9 |
| Erlotinib Hydrochloride | 11 | 45.8 | 45.9 |
| Erlotinib | 8 | 42.7 | 42.8 |
| Capecitabine | 65 | 42.7 | 42.7 |
| Ado-Trastuzumab Emtansine | 6 | 36.6 | 36.7 |
| Paclitaxel (Aibumin-Bound) | 50 | 35.0 | 35.1 |
| Docetaxel Anhydrous | 39 | 32.4 | 32.4 |
| Docetaxel | 39 | 32.4 | 32.4 |
| Pemetrexed | 13 | 31.8 | 31.8 |
| Ifosfamide | 13 | 31.7 | 31.7 |
| Paclitaxel | 53 | 31.1 | 31.1 |
| Trametinib | 13 | 28.2 | 28.2 |
| Regorafenib | 6 | 26.6 | 26.6 |
| Pemetrexed Disodium | 18 | 25.0 | 25.0 |
| Dabrafenib | 10 | 24.7 | 24.7 |
| Gemcitabine | 18 | 24.2 | 24.2 |
| Trastuzumab | 30 | 23.9 | 23.9 |
| Pazopanib Hydrochloride | 12 | 23.2 | 23.2 |
| Pertuzumab | 11 | 21.1 | 21.1 |
| Panitumumab | 6 | 19.7 | 19.7 |
| Cetuximab | 10 | 16.6 | 16.6 |
| Osimertinib | 10 | 16.2 | 16.2 |
| Palbociclib | 24 | 13.5 | 13.5 |
| Olaparib | 5 | 12.3 | 12.3 |